Marinomed Biotech AG logo

MARI - Marinomed Biotech AG News Story

€124 -1.0  -0.8%

Last Trade - 07/05/21

Sector
Healthcare
Size
Small Cap
Market Cap £159.2m
Enterprise Value £162.3m
Revenue £7.07m
Position in Universe 662nd / 1050

BRIEF-Marinomed Enrolls First Patient In Clinical Study Of Carragelose In COVID-19 Infections

Thu 25th March, 2021 6:47am
March 25 (Reuters) - MARINOMED BIOTECH AG  MARI.VI :
    * ENROLLS FIRST PATIENT IN CLINICAL STUDY OF INHALED
CARRAGELOSE
TO TREAT COVID-19 INFECTIONS

Source text for Eikon:  ID:nPexKRbJsa 
Further company coverage:  MARI.VI 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.